• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒 16 E6/E7 通过调控 miR-142-5p/PD-L1 轴促进宫颈癌的免疫逃逸和进展。

Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.

机构信息

Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.

Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.

出版信息

Arch Biochem Biophys. 2022 Nov 30;731:109449. doi: 10.1016/j.abb.2022.109449. Epub 2022 Oct 23.

DOI:10.1016/j.abb.2022.109449
PMID:36288761
Abstract

Persistent infection of human papillomavirus (HPV) and immune escape are the main causes of cervical cancer. E6/E7 encoded by HPV16 may be closely related to carcinogenesis. HPV infection may upregulate PD-L1 expression, resulting in immune escape and cervical cancerigenesis. Evidence indicates that miRNAs may mediate the regulation of E6/E7 on PD-L1. Therefore, we aimed to screen the miRNA, and further verify its expression and functions. Bioinformatics approaches were used to screen the miRNAs that mediate the regulation of E6/E7 on PD-L1. The expression of the miRNA and PD-L1 in HPV and HPV cervical cancer cells were compared, and the effect of E6E7 on them was evaluated. Then, the effect of the miRNA on PD-L1 was assessed by the Gain- and Loss-of-function test. Finally, in vivo experiments were conducted to verify the effects of the miRNA on tumor growth and survival of tumor-bearing mice. Six miRNAs were screened, of which miR-142-5p was identified. MiR-142-5p was downregulated and PD-L1 was upregulated in HPV cells after transfection of E6, E7, or E6/E7. The rescue test showed that the upregulation of miR-142-5p attenuated the effect of E6/E7 on PD-L1. The reverse relationship between PD-L1 and miR-142-5p was confirmed. In vivo experiments suggest that miR-142-5p upregulation inhibits the growth of the transplanted tumors by targeting PD-L1. MiR-142-5p acts as a tumor suppressor in cervical cancer. HPV16 E6E7 may promote the immune escape of cervical cancer cells by regulating the miR-142-5p/PD-L1 axis. Using miR-142-5p in tumor immunotherapy as a new strategy is proposed.

摘要

人乳头瘤病毒(HPV)的持续感染和免疫逃逸是宫颈癌的主要原因。HPV16 编码的 E6/E7 可能与致癌密切相关。HPV 感染可能上调 PD-L1 的表达,导致免疫逃逸和宫颈癌的发生。有证据表明,miRNA 可能介导 E6/E7 对 PD-L1 的调控。因此,我们旨在筛选 miRNA,并进一步验证其表达和功能。采用生物信息学方法筛选介导 E6/E7 对 PD-L1 调控的 miRNA。比较 HPV 和 HPV 宫颈癌细胞中 miRNA 和 PD-L1 的表达,并评价 E6E7 对它们的影响。然后,通过 Gain- 和 Loss-of-function 试验评估 miRNA 对 PD-L1 的影响。最后,进行体内实验验证 miRNA 对荷瘤小鼠肿瘤生长和生存的影响。筛选出 6 个 miRNA,其中 miR-142-5p 被鉴定。转染 E6、E7 或 E6/E7 后,HPV 细胞中的 miR-142-5p 下调,PD-L1 上调。挽救试验表明,miR-142-5p 的上调减弱了 E6/E7 对 PD-L1 的作用。证实了 PD-L1 和 miR-142-5p 之间的反向关系。体内实验表明,miR-142-5p 的上调通过靶向 PD-L1 抑制移植瘤的生长。miR-142-5p 在宫颈癌中起肿瘤抑制作用。HPV16 E6E7 可能通过调节 miR-142-5p/PD-L1 轴促进宫颈癌细胞的免疫逃逸。提出将 miR-142-5p 用于肿瘤免疫治疗作为一种新策略。

相似文献

1
Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.人乳头瘤病毒 16 E6/E7 通过调控 miR-142-5p/PD-L1 轴促进宫颈癌的免疫逃逸和进展。
Arch Biochem Biophys. 2022 Nov 30;731:109449. doi: 10.1016/j.abb.2022.109449. Epub 2022 Oct 23.
2
Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.人乳头瘤病毒(HPV)阳性肿瘤细胞中细胞内和外泌体微小RNA对病毒E6/E7癌基因表达的依赖性
PLoS Pathog. 2015 Mar 11;11(3):e1004712. doi: 10.1371/journal.ppat.1004712. eCollection 2015 Mar.
3
Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.人乳头瘤病毒 16 型 E7 癌蛋白诱导的赖氨酸特异性去甲基化酶 5A 的上调通过调节 microRNA-424-5p/抑制素 Zeste 12 通路促进宫颈癌的进展。
Exp Cell Res. 2020 Nov 1;396(1):112277. doi: 10.1016/j.yexcr.2020.112277. Epub 2020 Sep 10.
4
Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.人乳头瘤病毒 16 癌蛋白下调宫颈癌中 miR-148a-3p、miR-190a-5p 和 miR-199b-5p 的表达。
Biomed Res Int. 2018 Nov 29;2018:1942867. doi: 10.1155/2018/1942867. eCollection 2018.
5
HPV16 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway.HPV16 癌基因通过 miR-143/HIF-1a 通路调控 PD-L1 表达促进肿瘤免疫逃逸。
Viruses. 2024 Jan 12;16(1):113. doi: 10.3390/v16010113.
6
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.人乳头瘤病毒 E6/E7 和长非编码 RNA TMPOP2 相互上调宫颈癌细胞的基因表达。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01808-18. Print 2019 Apr 15.
7
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.人乳头瘤病毒16型癌基因E6或/和E7可能影响宫颈癌细胞系HT-3中RASSFIA基因启动子区域的甲基化状态。
Oncol Rep. 2017 Apr;37(4):2324-2334. doi: 10.3892/or.2017.5465. Epub 2017 Feb 17.
8
A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.一种针对 HPV16 E7 的治疗性 DNA 疫苗与抗 PD-1/PD-L1 联合增强肿瘤消退和细胞毒性免疫应答。
Int J Mol Sci. 2023 Oct 23;24(20):15469. doi: 10.3390/ijms242015469.
9
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.HPV16 E6 和 E7 通过 c-MYC/miR-146a-5p 轴上调组蛋白赖氨酸去甲基酶 KDM2B。
Oncogene. 2018 Mar;37(12):1654-1668. doi: 10.1038/s41388-017-0083-1. Epub 2018 Jan 16.
10
The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.HPV16E6、E7/miR-23b-3p/ICAT 信号轴促进宫颈癌细胞的增殖、迁移、侵袭和 EMT。
Carcinogenesis. 2023 May 27;44(3):221-231. doi: 10.1093/carcin/bgad008.

引用本文的文献

1
Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications.宫颈癌中的铁死亡-免疫相互作用:机制及治疗意义
Front Immunol. 2025 Aug 15;16:1657905. doi: 10.3389/fimmu.2025.1657905. eCollection 2025.
2
Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects.2010年至2024年宫颈癌与微小RNA研究的文献计量分析:研究趋势、热点与展望
Discov Oncol. 2025 Aug 27;16(1):1639. doi: 10.1007/s12672-025-03106-w.
3
Disruption Events in the HPV18 and Genes in Precancerous Cervical Lesions.
宫颈癌前病变中HPV18及相关基因的破坏事件
Int J Mol Sci. 2025 Jul 20;26(14):6974. doi: 10.3390/ijms26146974.
4
Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches.人乳头瘤病毒(HPV)与微小RNA的分子相互作用:对宫颈癌发展及治疗方法的见解
Infect Agent Cancer. 2025 Jul 23;20(1):49. doi: 10.1186/s13027-025-00677-9.
5
Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis.免疫检查点抑制剂治疗晚期宫颈癌的有效性和安全性:一项系统评价与荟萃分析
Front Immunol. 2025 Mar 11;16:1542850. doi: 10.3389/fimmu.2025.1542850. eCollection 2025.
6
Human cytomegalovirus tegument protein UL23 promotes gastric cancer immune evasion by facilitating PD-L1 transcription.人巨细胞病毒被膜蛋白UL23通过促进PD-L1转录来促进胃癌免疫逃逸。
Mol Med. 2025 Feb 11;31(1):57. doi: 10.1186/s10020-025-01114-8.
7
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.人乳头瘤病毒在癌症中的作用:致癌机制与临床应用
Signal Transduct Target Ther. 2025 Jan 24;10(1):44. doi: 10.1038/s41392-024-02083-w.
8
The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy.人乳头瘤病毒癌蛋白在宫颈癌程序性死亡配体1/程序性死亡受体1通路中的潜在作用:宫颈癌免疫治疗的新视角
Front Oncol. 2024 Dec 13;14:1488730. doi: 10.3389/fonc.2024.1488730. eCollection 2024.
9
Human umbilical cord mesenchymal stem cells small extracellular vesicles-derived miR-370-3p inhibits cervical precancerous lesions by targeting DHCR24.人脐带间充质干细胞小细胞外囊泡源性miR-370-3p通过靶向DHCR24抑制宫颈上皮内瘤变。
Stem Cells Transl Med. 2025 Jan 17;14(1). doi: 10.1093/stcltm/szae087.
10
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy.肿瘤中的免疫调节 microRNAs,其在诊断和治疗中的临床相关性。
J Immunother Cancer. 2024 Aug 29;12(8):e009774. doi: 10.1136/jitc-2024-009774.